| Brendan O'neill, MD | |
|
1490 N Turquoise Dr, Flagstaff, AZ 86001-1383 | |
| (928) 774-5074 | |
| (928) 779-0884 |
| Full Name | Brendan O'neill |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 17 Years |
| Location | 1490 N Turquoise Dr, Flagstaff, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013170695 | NPI | - | NPPES |
| 920324 | Medicaid | AZ |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Arizona Dermatology Center Pc | 8527951052 | 9 |
News Archive
The Washington Post examines how drugs administered by doctors is different in various regions of the country. Other outlets look at other issues, including how eye doctors are among the highest paid specialty.
Autism prevalence among 8-year-old Utah children has risen by nearly 30% in less than a decade, according to a study of 11 communities nationwide, including Salt Lake City and surrounding counties, led by the Centers for Disease Control and Prevention.
Lakeside Medical Organization and CEO Dr. Richard Merkin have been honored by the Glendale Chamber of Commerce for significant community outreach.
Millennium: The Takeda Oncology Company today reported results from a randomized, international Phase III clinical trial comparing subcutaneous and intravenous administration of VELCADE (bortezomib) in patients with relapsed multiple myeloma. These data were presented at the 52nd annual meeting of the American Society of Hematology, held December 4-7 in Orlando, Florida.
BioTime, Inc. today announced that it has obtained an exclusive license from The Wistar Institute in Philadelphia, PA for technology related to a gene designated as SP100.
› Verified 8 days ago
| Entity Name | Northern Arizona Dermatology Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962558569 PECOS PAC ID: 8527951052 Enrollment ID: O20040206000555 |
News Archive
The Washington Post examines how drugs administered by doctors is different in various regions of the country. Other outlets look at other issues, including how eye doctors are among the highest paid specialty.
Autism prevalence among 8-year-old Utah children has risen by nearly 30% in less than a decade, according to a study of 11 communities nationwide, including Salt Lake City and surrounding counties, led by the Centers for Disease Control and Prevention.
Lakeside Medical Organization and CEO Dr. Richard Merkin have been honored by the Glendale Chamber of Commerce for significant community outreach.
Millennium: The Takeda Oncology Company today reported results from a randomized, international Phase III clinical trial comparing subcutaneous and intravenous administration of VELCADE (bortezomib) in patients with relapsed multiple myeloma. These data were presented at the 52nd annual meeting of the American Society of Hematology, held December 4-7 in Orlando, Florida.
BioTime, Inc. today announced that it has obtained an exclusive license from The Wistar Institute in Philadelphia, PA for technology related to a gene designated as SP100.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brendan O'neill, MD 1490 N Turquoise Dr, Flagstaff, AZ 86001-1383 Ph: (928) 774-5074 | Brendan O'neill, MD 1490 N Turquoise Dr, Flagstaff, AZ 86001-1383 Ph: (928) 774-5074 |
News Archive
The Washington Post examines how drugs administered by doctors is different in various regions of the country. Other outlets look at other issues, including how eye doctors are among the highest paid specialty.
Autism prevalence among 8-year-old Utah children has risen by nearly 30% in less than a decade, according to a study of 11 communities nationwide, including Salt Lake City and surrounding counties, led by the Centers for Disease Control and Prevention.
Lakeside Medical Organization and CEO Dr. Richard Merkin have been honored by the Glendale Chamber of Commerce for significant community outreach.
Millennium: The Takeda Oncology Company today reported results from a randomized, international Phase III clinical trial comparing subcutaneous and intravenous administration of VELCADE (bortezomib) in patients with relapsed multiple myeloma. These data were presented at the 52nd annual meeting of the American Society of Hematology, held December 4-7 in Orlando, Florida.
BioTime, Inc. today announced that it has obtained an exclusive license from The Wistar Institute in Philadelphia, PA for technology related to a gene designated as SP100.
› Verified 8 days ago
Carl Frederick Bigler, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1490 N Turquoise Dr, Flagstaff, AZ 86001 Phone: 928-774-5074 Fax: 928-779-0884 | |
Dr. Jordan J Miller, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1490 N Turquoise Dr, Flagstaff, AZ 86001 Phone: 928-774-5074 Fax: 928-779-0884 | |
Angela J Wyatt, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 150 N Verde St Ste 101, Flagstaff, AZ 86001 Phone: 928-779-6923 Fax: 928-779-6924 | |
Scott Morrison Dale, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1490 N Turquoise Dr, Flagstaff, AZ 86001 Phone: 928-774-5074 Fax: 928-779-0884 | |
Edward Charles Kauffman, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1490 N Turquoise Dr, Flagstaff, AZ 86001 Phone: 928-774-5074 Fax: 928-779-0884 | |
Therese Ann Holguin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1490 N Turquoise Dr, Flagstaff, AZ 86001 Phone: 928-774-5074 Fax: 928-779-0884 |